← Back to Screener
3M Company (MMM)
Price$153.76
Value ScoreC
Growth ScoreF
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-18.56%
Price vs S&P 500 (4W)7.32%
VGM Score42.05
Market Capitalization$80.20B
P/E Ratio (Annual)24.68x
Indicated Dividend Yield (Annual)2.04%
All Metrics
P/CF (Annual)35.48x
Book Value / Share (Quarterly)$6.26
P/TBV (Annual)23.63x
Indicated Dividend (Annual)$3.12
Revenue Growth (3Y)-1.57%
Cash Flow / Share (Quarterly)$3.83
Payout Ratio (TTM)56.62%
Price vs S&P 500 (YTD)-12.12%
Gross Margin (TTM)39.71%
Net Profit Margin (TTM)11.14%
EPS (TTM)$5.18
10-Day Avg Trading Volume3.39M
EPS Excl Extra (TTM)$5.18
Revenue Growth (5Y)-4.97%
EPS (Annual)$6.00
Dividend / Share (Annual)$2.92
ROI (Annual)18.78%
Gross Margin (Annual)39.92%
Net Profit Margin (5Y Avg)8.08%
Cash / Share (Quarterly)$7.95
P/E Basic Excl Extra (TTM)28.78x
Revenue Growth QoQ (YoY)1.28%
EPS Growth (5Y)-8.50%
P/E Normalized (Annual)24.68x
ROA (Last FY)8.61%
Revenue Growth TTM (YoY)2.08%
EBITD / Share (TTM)$11.39
ROE (5Y Avg)22.16%
Operating Margin (TTM)19.10%
Cash Flow / Share (Annual)$2.55
P/B Ratio24.58x
P/B Ratio (Quarterly)23.21x
Net Income / Employee (Annual)$53,700
EV / Revenue (TTM)3.56x
Net Interest Coverage (TTM)14.50x
ROA (TTM)7.49%
EPS Growth QoQ (YoY)-39.85%
EV / EBITDA (TTM)14.54x
EPS Incl Extra (Annual)$6.00
Current Ratio (Annual)1.71x
Quick Ratio (Quarterly)1.14x
3-Month Avg Trading Volume3.95M
52-Week Price Return5.13%
EV / Free Cash Flow (Annual)65.94x
P/E Incl Extra (TTM)28.78x
Revenue / Employee (TTM)$413,600
Tangible BV / Share (Quarterly)$4.19
P/S Ratio (Annual)3.21x
Asset Turnover (Annual)0.66x
52-Week High$177.41
Operating Margin (5Y Avg)6.45%
EPS Excl Extra (Annual)$6.00
CapEx CAGR (5Y)-9.52%
Tangible BV CAGR (5Y)-12.54%
26-Week Price Return-10.63%
Quick Ratio (Annual)1.29x
13-Week Price Return-1.57%
Total Debt / Equity (Annual)2.68x
Current Ratio (Quarterly)1.59x
Enterprise Value$89.02B
Revenue / Share Growth (5Y)-3.57%
Asset Turnover (TTM)0.67x
Book Value / Share Growth (5Y)-16.82%
Revenue / Employee (Annual)$412,400
Inventory Turnover (Annual)4.07x
Pretax Margin (Annual)16.89%
Cash / Share (Annual)$11.19
3-Month Return Std Dev26.48%
Gross Margin (5Y Avg)41.40%
Net Income / Employee (TTM)$46,100
EBITDA CAGR (5Y)-8.11%
EBITDA Interim CAGR (5Y)-6.74%
ROE (Last FY)69.12%
Net Interest Coverage (Annual)4.71x
EPS Basic Excl Extra (Annual)$6.00
P/FCF (TTM)25.39x
Receivables Turnover (TTM)6.90x
EV / Free Cash Flow (TTM)44.58x
Total Debt / Equity (Quarterly)3.85x
EPS Incl Extra (TTM)$5.18
Receivables Turnover (Annual)7.42x
ROI (TTM)16.44%
Dividend Growth Rate (5Y)-13.05%
P/S Ratio (TTM)3.20x
Pretax Margin (5Y Avg)5.43%
Revenue / Share (Annual)$46.09
Tangible BV / Share (Annual)$6.79
Forward P/E16.99x
Free OCF CAGR (5Y)-27.22%
Price vs S&P 500 (52W)-19.24%
P/E Ratio (TTM)28.78x
EPS Growth TTM (YoY)-34.52%
Year-to-Date Return-3.96%
5-Day Price Return1.88%
EPS Normalized (Annual)$6.00
ROA (5Y Avg)6.05%
Net Profit Margin (Annual)13.03%
Month-to-Date Return0.41%
Cash Flow / Share (TTM)$-9.92
EBITD / Share (Annual)$10.97
EPS Growth (3Y)-16.13%
Operating Margin (Annual)18.55%
LT Debt / Equity (Annual)2.33x
P/CF (TTM)27.69x
ROI (5Y Avg)9.39%
P/E Excl Extra (TTM)28.78x
LT Debt / Equity (Quarterly)3.34x
EPS Basic Excl Extra (TTM)$5.18
P/TBV (Quarterly)34.67x
Payout Ratio (Annual)48.06%
P/B Ratio (Annual)18.09x
Dividend / Share (TTM)$2.98
Inventory Turnover (TTM)3.99x
Pretax Margin (TTM)14.81%
Book Value / Share (Annual)$8.87
Price vs S&P 500 (13W)-9.82%
Net Margin Growth (5Y)-5.10%
Dividend Yield (TTM)1.97%
Beta1.02x
P/FCF (Annual)59.40x
Revenue / Share (TTM)$46.97
ROE (TTM)66.03%
52-Week Low$139.34
vGradeC
gGradeF
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 262.14est. 2.00
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
3.71
3.71
3.71
3.74
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MMM3M Company | C | F | C | $153.76 |
| SYKStryker Corporation | C | C | C | $305.66 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
| GMEDGLOBUS MEDICAL INC | B | A | C | $80.00 |
About
3M is a multinational industrial conglomerate with a diversified product portfolio across safety and industrial solutions (44% of revenue), transportation and electronics (36%), and consumer goods (20%). The company leverages proprietary technologies and strong R&D capabilities to develop innovative products across thousands of offerings worldwide. With operations spanning the globe, 3M generates nearly half its revenue internationally. In 2024, the company separated its healthcare business into an independent entity, Solventum, to focus on its core industrial and consumer segments.